Headlines

Analyst Expectations For Apellis Pharmaceuticals’s Future

Latest Ratings for APLS

Date Firm Action From To
Mar 2022 Goldman Sachs Maintains Buy
Mar 2022 Raymond James Maintains Strong Buy
Jan 2022 Raymond James Maintains Strong Buy

View More Analyst Ratings for APLS

View the Latest Analyst Ratings

read more

Leave a Reply

Your email address will not be published. Required fields are marked *